603108.SS SHH
Shanghai Runda Medical Technology Co., Ltd.
1W: -2.0%
1M: +1.0%
3M: +7.2%
YTD: -40.0%
1Y: -45.7%
3Y: -31.7%
5Y: -7.1%
¥9.97 ($1.49)
-0.11 (-1.09%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$14.3B
-0.0% ▼
5Y CAGR: +9.6%
Total Liabilities
$8.7B
-1.8% ▼
5Y CAGR: +9.5%
Shareholders Equity
$4.4B
+1.7% ▲
5Y CAGR: +9.6%
Cash & Investments
$1.3B
+14.4% ▲
5Y CAGR: +6.0%
Total Debt
$5.9B
-14.1% ▼
5Y CAGR: +13.9%
Net Debt
$4.7B
-3.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $835M | $1.0B | $1.0B | $1.1B | $1.2B |
| Short-Term Investments | $170M | $25M | $106M | $242M | $82M |
| Cash & ST Investments | $1.0B | $1.0B | $1.1B | $1.1B | $1.3B |
| Net Receivables | $3.6B | $4.5B | $6.3B | $5.9B | $5.5B |
| Inventory | $1.2B | $1.5B | $1.6B | $1.4B | $1.3B |
| Other Current Assets | $587M | $599M | $33M | $11K | $110M |
| Total Current Assets | $6.2B | $7.4B | $9.8B | $9.4B | $9.2B |
| Property, Plant & Equip. | $932M | $1.2B | $1.2B | $1.2B | $1.1B |
| Goodwill & Intangibles | $1.9B | $2.0B | $2.1B | $2.1B | $2.1B |
| Long-Term Investments | $726M | $1.1B | $1.0B | $1.2B | $1.4B |
| Other Non-Current Assets | $325M | $182M | $260M | $172M | $239M |
| Total Non-Current Assets | $3.9B | $4.6B | $4.7B | $4.9B | $5.1B |
| Total Assets | $10.2B | $12.0B | $14.5B | $14.3B | $14.3B |
| — Liabilities — | |||||
| Accounts Payable | $938M | $1.2B | $1.8B | $1.4B | $1.2B |
| Short-Term Debt | $4.0B | $4.2B | $5.2B | $5.2B | $4.9B |
| Deferred Revenue | $558M | $630M | $186M | $0 | $0 |
| Other Current Liabilities | -$302M | $185M | $1.3B | $809M | $1.1B |
| Total Current Liabilities | $5.5B | $6.2B | $8.5B | $7.5B | $7.5B |
| Long-Term Debt | $480M | $1.2B | $824M | $1.1B | $887M |
| Other Non-Current Liab. | -$53M | $96M | $35M | $74M | $142M |
| Total Non-Current Liabilities | $553M | $1.4B | $1.0B | $1.3B | $1.2B |
| Total Liabilities | $6.1B | $7.6B | $9.5B | $8.9B | $8.7B |
| — Equity — | |||||
| Common Stock | $580M | $580M | $580M | $597M | $604M |
| Retained Earnings | $1.5B | $1.8B | $2.2B | $2.3B | $2.3B |
| Accumulated OCI | $176M | $210M | $218M | $0 | $0 |
| Total Stockholders Equity | $3.2B | $3.5B | $3.9B | $4.3B | $4.4B |
| Total Liabilities & Equity | $10.2B | $12.0B | $14.5B | $14.3B | $14.3B |
| — Key Metrics — | |||||
| Total Debt | $4.5B | $5.7B | $6.9B | $6.9B | $5.9B |
| Net Debt | $3.7B | $4.7B | $5.9B | $4.8B | $4.7B |
| Total Investments | $895M | $1.1B | $1.1B | $1.5B | $1.5B |